Basidiomycota

Chiber From Chinova Bioworks Gives Plant-Based Meat Alternatives the Advantage

Retrieved on: 
Wednesday, July 21, 2021
Food and drink, Vegetarian cuisine, Cuisine, Foods, Meat substitutes, Packaging, Basidiomycota, Mushroom, Shelf life, Meat analogue, Edible mushroom, Preservative

Chiber from Chinova Bioworks is a clean-label, natural fiber derived from the stems of white button mushrooms that is the solution to extend shelf life of refrigerated plant-based meats while also improving quality and freshness.

Key Points: 
  • Chiber from Chinova Bioworks is a clean-label, natural fiber derived from the stems of white button mushrooms that is the solution to extend shelf life of refrigerated plant-based meats while also improving quality and freshness.
  • Mushrooms are on the rise and within the plant-based meat industry as a great protein alternative to conventional meat, but we have discovered that mushrooms can be used for much more than that, said Natasha Dhayagude, CEO and co-founder of Chinova Bioworks.
  • Consumers expect plant-based alternatives to imitate all aspects of conventional products especially when it comes to the taste and shelf life.
  • Chinova Bioworks is a food technology company with a five-year track record of developing natural, clean-label preservatives extracted from mushrooms for the food and beverage industry.

Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

Retrieved on: 
Tuesday, June 8, 2021
Fungi, Edible fungi, Non-timber forest products, Basidiomycota, Mushroom, Food and drink, Edible mushroom, Organisms

Most mushrooms, especially the noxious species, have not been investigated for their chemical components, says Senior Scientist, Duff Sloley.

Key Points: 
  • Most mushrooms, especially the noxious species, have not been investigated for their chemical components, says Senior Scientist, Duff Sloley.
  • Most of these compounds are evolved to protect the mushrooms fruiting body from predation by insects, nematodes and bacteria and are complex and metabolically expensive to produce.
  • We have seen accelerated progress through Mydecines fully integrated research and cultivation facilities, stated Josh Bartch, CEO of Mydecine.
  • Mydecine also operates out of a state-of-the-art mycology lab in Denver, CO to focus on genetic research for scaling commercial cultivation of rare (non-psychedelic) medicinal mushrooms.

Reishi Mushroom Market to Generate $5.06 Bn, Globally, by 2027 at 8.1% CAGR: AMR

Retrieved on: 
Tuesday, April 13, 2021
Non-timber forest products, Fungi, Ganodermataceae, Organisms, Lingzhi, Medicinal fungi, Basidiomycota, Mushroom, Shrooms

Moreover, rise in consumer spending and health consciousness among consumers supplement the market growth.

Key Points: 
  • Moreover, rise in consumer spending and health consciousness among consumers supplement the market growth.
  • However, high price of reishi mushrooms hinders the market growth.
  • However, the powder segment held the lion\'s share in 2019, accounting for around three-fifths of the global reishi mushroom market, as it offers essential nutrients as compared to its fresh version.\nBy nature, the conventional segment dominated the market in 2019, contributing to more than three-fifths of the global reishi mushroom market, as conventionally-sourced mushrooms are economical and widely used in industrial production.
  • However, the market across Asia-Pacific is anticipated to manifest the highest CAGR of 7.3% during the forecast period, owing totremendous popularity and substantial consumption of reishi mushroom products in the region.\n'

Reishi Mushroom Market to Generate $5.06 Bn, Globally, by 2027 at 8.1% CAGR: AMR

Retrieved on: 
Tuesday, April 13, 2021
Non-timber forest products, Fungi, Ganodermataceae, Organisms, Lingzhi, Medicinal fungi, Basidiomycota, Mushroom, Shrooms

Moreover, rise in consumer spending and health consciousness among consumers supplement the market growth.

Key Points: 
  • Moreover, rise in consumer spending and health consciousness among consumers supplement the market growth.
  • However, high price of reishi mushrooms hinders the market growth.
  • However, the powder segment held the lion\'s share in 2019, accounting for around three-fifths of the global reishi mushroom market, as it offers essential nutrients as compared to its fresh version.\nBy nature, the conventional segment dominated the market in 2019, contributing to more than three-fifths of the global reishi mushroom market, as conventionally-sourced mushrooms are economical and widely used in industrial production.
  • However, the market across Asia-Pacific is anticipated to manifest the highest CAGR of 7.3% during the forecast period, owing totremendous popularity and substantial consumption of reishi mushroom products in the region.\n'

New Wave Subsidiary, Way of Will Inc., Announces Launch of Functional Mushroom Capsules and Functional Mushroom Powder as Part of New Emerging Mushroom Collection

Retrieved on: 
Thursday, March 25, 2021
Fungi, Non-timber forest products, Entheogens, Psychoactive fungi, Basidiomycota, Edible fungi, Mushroom, Psychedelic drug, Organisms

Further to the announcement, the company is releasing the Functional Mushroom Powder and the Functional Mushroom Capsules from the collection to the U.S. market.

Key Points: 
  • Further to the announcement, the company is releasing the Functional Mushroom Powder and the Functional Mushroom Capsules from the collection to the U.S. market.
  • Paving the way to a larger collection of specialty mushroom products, the mushroom powder and capsules will be the first step in Way of Will's journey into the psychedelics space.
  • The product launch, featuring a house blend of five functional mushrooms and fungi available in both capsule and powder format, aim to naturally boost immunity.
  • They are loaded with vitamins, nutrients, and antioxidants that support a healthy immune system.

Pure Extracts Orders First Shipment of Functional Mushrooms for e-Commerce Store

Retrieved on: 
Tuesday, March 16, 2021
Fungi, Non-timber forest products, Basidiomycota, Edible fungi, Mushroom, Pure, Organisms, Entheogens, Psychoactive fungi

VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (Pure Extracts or the Company), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Mushrooms Corp. (Pure Mushrooms), has ordered its first shipment of functional mushrooms from its British Columbia co-packer.

Key Points: 
  • VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (Pure Extracts or the Company), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Mushrooms Corp. (Pure Mushrooms), has ordered its first shipment of functional mushrooms from its British Columbia co-packer.
  • Pure Mushrooms has developed three premium, functional mushroom formulations, that come in safe and convenient vegan capsules.
  • Pure Extracts CEO, Ben Nikolaevsky, remarked, We are excited to be ordering the first Pure Mushrooms products to launch our direct-to-consumer, online store.
  • About Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)
    Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia.

NeonMind Announces Grants Pursuant to Stock Option Plan

Retrieved on: 
Tuesday, January 12, 2021
Fungi, Non-timber forest products, Options, Basidiomycota, Edible fungi, Mushroom, Incentive stock option, Hallucinogen, Organisms

Vancouver, British Columbia--(Newsfile Corp. - January 11, 2021) - NeonMind Biosciences Inc. (CSE: NEON) ("NeonMind"), a psychedelic drug development company, granted a total of 5,940,000 incentive stock options.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - January 11, 2021) - NeonMind Biosciences Inc. (CSE: NEON) ("NeonMind"), a psychedelic drug development company, granted a total of 5,940,000 incentive stock options.
  • 250,000 were granted to directors, 4,900,000 were granted to officers and 790,000 were granted to consultants under the Company's incentive stock option plan (the "Plan").
  • NeonMind is developing and commercializing products that contain legal medicinal mushrooms and products that may contain psychedelic compounds.
  • For more information on NeonMind Biosciences, go to www.NeonMindBiosciences.com or buy NeonMind mushroom infused coffee at www.NeonMind.com .

Global Mushroom Market (2020 to 2025) - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 1, 2020
Food, Beverage, Retail, Edible fungi, Non-timber forest products, Organisms, Basidiomycota, Mushroom, Compound annual growth rate, Academic disciplines, Articles

The "Mushroom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Mushroom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • The global mushroom market reached a value of 53.7 Billion in 2019.
  • Looking forward, the publisher expects the market to reach a value of US$ 86.6 Billion by 2025, registering a CAGR of 8.3% during 2020-2025.
  • Mushroom is a kind of fungi that is widely considered to be edible and forms an integral part of various cuisines across the globe.

As Health-Conscious Consumers Seek Fresh Nutritional Avenues, Artisanal Mushrooms Step Into the Light

Retrieved on: 
Thursday, April 2, 2020
Non-timber forest products, Edible fungi, Organisms, Basidiomycota, Mushroom, Chaga people, Lion's mane, Traditional knowledge

For decades, these mushrooms have played a part in alternative culturea subversive option for those looking to expand their minds.

Key Points: 
  • For decades, these mushrooms have played a part in alternative culturea subversive option for those looking to expand their minds.
  • However, a better understanding of mushrooms and safe techniques to process them have made other options become available.
  • Champignon's Vitality Teas brand offers a range of teas infused with ingredients derived from the most desirable artisanal medical mushrooms Reishi, Chaga and Lion's Mane.
  • Champignon's strategy involves cultivating and distributing artisanal medical mushrooms and products derived from them, while maintaining control of its whole product chain.

As Health-Conscious Consumers Seek Fresh Nutritional Avenues, Artisanal Mushrooms Step Into the Light

Retrieved on: 
Thursday, April 2, 2020
Non-timber forest products, Edible fungi, Organisms, Basidiomycota, Mushroom, Chaga people, Lion's mane, Traditional knowledge

For decades, these mushrooms have played a part in alternative culturea subversive option for those looking to expand their minds.

Key Points: 
  • For decades, these mushrooms have played a part in alternative culturea subversive option for those looking to expand their minds.
  • However, a better understanding of mushrooms and safe techniques to process them have made other options become available.
  • Champignon's Vitality Teas brand offers a range of teas infused with ingredients derived from the most desirable artisanal medical mushrooms Reishi, Chaga and Lion's Mane.
  • Champignon's strategy involves cultivating and distributing artisanal medical mushrooms and products derived from them, while maintaining control of its whole product chain.